Skip to main content
Log in

GFR may not accurately predict aspects of proximal tubule drug handling

  • Pharmacokinetics and Disposition
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

Dose modification in renal impairment has traditionally been based on changes in estimated glomerular filtration rate (eGFR; estimated by creatinine clearance). However, many drugs are eliminated by tubular anionic and cationic transport where changes in eGFR may not necessarily reflect changes in tubular function. This study investigated the relationship between GFR and renal tubular function with reference to drug handling by using accepted drug probes.

Methods

Three drug probes, 51Cr-EDTA, fluconazole, and pindolol, were administered to patients who had varying degrees of renal impairment. Blood sampling, assays, and a pharmacokinetic analysis were performed for all drug probes and endogenous urate. Measured GFR (51Cr-EDTA clearance; mGFR) was compared to tubular anionic transport (urate clearance), tubular reabsorption (fluconazole clearance), and tubular cationic transport (S-pindolol clearance).

Results

A moderately strong association was demonstrated between the measured isotopic GFR and creatinine clearance (R2 = 0.78). A moderate positive correlation was found between mGFR and proximal tubular anion transport and reabsorption (R2 = 0.40–0.44, p < 0.0001). In contrast, cationic secretion correlated poorly with mGFR (R2 = 0.11, p = 0.036).

Conclusions

Given that drug dosing schedules utilise eGFR values as the basis for modifying drug dosing, our results would suggest that a recommendation of a dose reduction according to eGFR alone should be treated with caution.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Vidal L, Shavit M, Fraser A, Paul M, Leibovici L (2005) Systematic comparison of four sources of drug information regarding adjustment of dose for renal function. BMJ 331(7511):263. doi:10.1136/bmj.38476.471088.3A

    Article  PubMed Central  PubMed  Google Scholar 

  2. Botev R, Mallie JP, Wetzels JF, Couchoud C, Schuck O (2011) The clinician and estimation of glomerular filtration rate by creatinine-based formulas: Current limitations and quo vadis. Clin J Am Soc Nephrol 6(4):937–950. doi:10.2215/CJN.09241010

    Article  PubMed  Google Scholar 

  3. Dontas AS, Marketos SG, Papanayiotou P (1972) Mechanisms of renal tubular defects in old age. Postgrad Med J 48(559):295–303

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Lindeman RD (1990) Overview: Renal physiology and pathophysiology of aging. Am J Kidney Dis 16(4):275–282

    Article  CAS  PubMed  Google Scholar 

  5. Lindeman RD (1992) Changes in renal function with aging. Implications for treatment. Drugs Aging 2(5):423–431

    Article  CAS  PubMed  Google Scholar 

  6. Lindeman RD (1993) Renal physiology and pathophysiology of aging. Contrib Nephrol 105:1–12

    CAS  PubMed  Google Scholar 

  7. (K/DOQI) KDOQI (2002) K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S246

    Google Scholar 

  8. Nolin TD, Naud J, Leblond FA, Pichette V (2008) Emerging evidence of the impact of kidney disease on drug metabolism and transport. Clin Pharmacol Ther 83(6):898–903. doi:10.1038/clpt.2008.59

    Article  CAS  PubMed  Google Scholar 

  9. Tett SE, Kirkpatrick CM, Gross AS, McLachlan AJ (2003) Principles and clinical application of assessing alterations in renal elimination pathways. Clin Pharmacokinet 42(14):1193–1211

    Article  PubMed  Google Scholar 

  10. Gross AS, McLachlan AJ, Minns I, Beal JB, Tett SE (2001) Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol. Br J Clin Pharmacol 51(6):547–555

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. McLachlan AJ, Gross AS, Beal JL, Minns I, Tett SE (2001) Analytical validation for a series of marker compounds used to assess renal drug elimination processes. Ther Drug Monit 23(1):39–46

    Article  CAS  PubMed  Google Scholar 

  12. Andreev E, Koopman M, Arisz L (1999) A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? J Intern Med 246(3):247–252

    Article  CAS  PubMed  Google Scholar 

  13. Cappuccio FP, Iacone R, Strazzullo P (1991) Serum uric acid and proximal sodium excretion: an independent association in man (the Olivetti Study). J Hypertens Suppl 9(6):S280–S281

    Article  CAS  PubMed  Google Scholar 

  14. Beal JL, Tett SE (1998) Determination of pindolol enantiomers in human plasma and urine by simple liquid-liquid extraction and high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 715(2):409–415

    Article  CAS  PubMed  Google Scholar 

  15. Kim SS, Im HT, Kang IM, Lee HS, Lee HW, Cho SH, Kim JB, Lee KT (2007) An optimized analytical method of fluconazole in human plasma by high-performance liquid chromatography with ultraviolet detection and its application to a bioequivalence study. J Chromatogr B Anal Technol Biomed Life Sci 852(1–2):174–179. doi:10.1016/j.jchromb.2007.01.012

    Article  CAS  Google Scholar 

  16. Chantler C, Garnett ES, Parsons V, Veall N (1969) Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. Clin Sci 37(1):169–180

    CAS  PubMed  Google Scholar 

  17. Du Bois D, Du Bois EF (1989) A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 5(5):303–311, discussion 312–303

    PubMed  Google Scholar 

  18. Maesaka JK, Fishbane S (1998) Regulation of renal urate excretion: a critical review. Am J Kidney Dis 32(6):917–933

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by a Laurenson Grant awarded from the Otago Medical Research Foundation. Dr Putt was the recipient of an Otago University Emily Johnston Scholarship. Mr Ashley Duncan, Department of Human Nutrition, University of Otago, kindly undertook the pindolol and fluconazole assays as well as the routine biochemical assays. This work was presented in abstract form at the World Congress of Nephrology, Hong Kong 2013.

Conflict of interest

The authors have no financial conflicts of interest.

Author contributions

Dr Putt planned and conducted the study, analysed the GFR, and was the primary author of the manuscript. Professor Walker was the primary investigator and co-wrote the manuscript. Professor Duffull conducted the NONMEM analysis and assisted with manuscript preparation. Dr Schollum was involved in the planning of the study along with the other authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen B. Duffull.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 246 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Putt, T.L., Duffull, S.B., Schollum, J.B.W. et al. GFR may not accurately predict aspects of proximal tubule drug handling. Eur J Clin Pharmacol 70, 1221–1226 (2014). https://doi.org/10.1007/s00228-014-1733-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-014-1733-7

Keywords

Navigation